Verition Fund Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.56M | Buy |
|
|||||
|
2025
Q1 | $1.07M | Sell |
|
|||||
|
2024
Q4 | $2.65M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $236K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $355K | Sell |
|
|||||
|
2022
Q3 | $383K | Sell |
|
|||||
|
2022
Q2 | $525K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $435K | Sell |
|
|||||
|
2020
Q2 | $939K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $204K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $546K | Sell |
|
|||||
|
2018
Q4 | $753K | Buy |
|
|||||
|
2018
Q3 | $690K | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $245K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $584K | Buy |
|
|||||
|
2016
Q4 | $257K | Buy |
|
|||||
|
2016
Q3 | $253K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.01M | Buy |
|
|||||
|
2015
Q3 | – | Sell |
|
|||||
|
2015
Q2 | $260K | Sell |
|
|||||
|
2015
Q1 | $358K | Buy |
|